ADMA Biologics ADMA Enterprise value

Enterprise value at other companies

AbCellera Biologics Inc.ABCL

$2.39B+113%

Lifecore Biomedical, Inc.LFCR

$155.49M—

AnaptysBio, Inc.ANAB

$1.35B+176%

Absci CorporationABSI

$453.38M+73.1%

Avalo TherapeuticsAVTX

$886.04M+7,437%

Apogee Therapeutics, Inc.APGE

$5.84B+181%

FAQ

What is ADMA Biologics's enterprise value?

ADMA Biologics (ADMA) reported enterprise value of $2.01B in Q2 2026.

How has ADMA Biologics's enterprise value changed year-over-year?

ADMA Biologics's enterprise value decreased by 52.0% year-over-year, from $4.18B to $2.01B.

What is the long-term trend for ADMA Biologics's enterprise value?

Over 5 years (2020 to 2025), ADMA Biologics's enterprise value has grown at a 59.2% compound annual growth rate (CAGR), from $423.58M to $4.33B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.